TrialBritish journal of clinical pharmacology2019

A phase 1 healthy male volunteer single escalating dose study of the pharmacokinetics and pharmacodynamics of risdiplam (RG7916, RO7034067), a SMN2 splicing modifier.

Stefan Sturm et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.